Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Goossens

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Swiss Medical Weekly|July 23, 2019
Non-invasive diagnosis of liver steatosis: ready for primetime?Nicolas Goossens
Hepatology (Baltimore, Md.)|October 25, 2013
Is genotype 3 of the hepatitis C virus the new villain?Nicolas Goossens, Francesco Negro
Revue Medicale Suisse|October 13, 2011
[New treatments for hepatitis C, which targets, what timeline?]Nicolas Goossens, Francesco Negro
Reviews on Recent Clinical Trials|December 18, 2014
Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infectionNicolas Goossens, Francesco Negro
Clinical and Molecular Hepatology|July 10, 2015
Hepatitis C virus-induced hepatocellular carcinomaNicolas Goossens, Yujin Hoshida
Clinical Liver Disease|May 2, 2019
Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futurasNicolas Goossens, Yujin Hoshida
Gastroenterology|January 20, 2016
Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?Nicolas Goossens, Yujin Hoshida
Revue Medicale Suisse|July 14, 2017
Laurent Spahr, Nicolas Goossens
Clinics in Liver Disease|July 11, 2017
Cardiovascular Manifestations of Hepatitis C VirusNicolas Goossens, Francesco Negro
Clinical Liver Disease|July 28, 2015
Personalized management of hepatocellular carcinoma based on molecular information: future prospectsNicolas Goossens, Yujin Hoshida
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Swiss Medical Weekly|July 23, 2019
Non-invasive diagnosis of liver steatosis: ready for primetime?Nicolas Goossens
Hepatology (Baltimore, Md.)|October 25, 2013
Is genotype 3 of the hepatitis C virus the new villain?Nicolas Goossens, Francesco Negro
Revue Medicale Suisse|October 13, 2011
[New treatments for hepatitis C, which targets, what timeline?]Nicolas Goossens, Francesco Negro
Reviews on Recent Clinical Trials|December 18, 2014
Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infectionNicolas Goossens, Francesco Negro
Clinical and Molecular Hepatology|July 10, 2015
Hepatitis C virus-induced hepatocellular carcinomaNicolas Goossens, Yujin Hoshida
Clinical Liver Disease|May 2, 2019
Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futurasNicolas Goossens, Yujin Hoshida
Gastroenterology|January 20, 2016
Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?Nicolas Goossens, Yujin Hoshida
Revue Medicale Suisse|July 14, 2017
Laurent Spahr, Nicolas Goossens
Clinics in Liver Disease|July 11, 2017
Cardiovascular Manifestations of Hepatitis C VirusNicolas Goossens, Francesco Negro
Clinical Liver Disease|July 28, 2015
Personalized management of hepatocellular carcinoma based on molecular information: future prospectsNicolas Goossens, Yujin Hoshida
Pageof 11